← back to search

Xiaojuan Mi

Shaanxi University of Chinese Medicine · CN
Area of research
Cardiology and Cardiovascular Medicine · Family Practice
Research interest
Research interests include Heart Failure Treatment and Management, Cardiac pacing and defibrillation studies, Atrial Fibrillation Management and Outcomes, and Cardiovascular Function and Risk Factors.
h-index
28
citations
3,492
works
80
NIH funding
primary concept
email

Recent publications

The Alzheimer’s Disease Cooperative Study – Activities of Daily Living dependence score: revision and validation of an algorithm evaluating patient dependence across the spectrum of AD severity
The Journal of Prevention of Alzheimer s Disease 2025cited by 1position: middledoi
Target Doses of Heart Failure Medical Therapy and Blood Pressure
JACC Heart Failure 2019cited by 103position: middledoi
Medical Therapy for Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology 2018cited by 1,254position: middledoi
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences
JAMA Cardiology 2018cited by 76position: middledoi
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction
JACC Heart Failure 2017cited by 132position: middledoi
Outcomes Associated With Extraction Versus Capping and Abandoning Pacing and Defibrillator Leads
Circulation 2017cited by 73position: middledoi
Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure
American Heart Journal 2013cited by 95position: middledoi
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction
JAMA 2012cited by 142position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Adrian F. Hernandez · Duke University5 papers (2012–2019)Gregg C. Fonarow · UCLA Medical Center5 papers (2012–2019)Lesley H. Curtis · Duke University3 papers (2012–2017)Paul A. Heidenreich · Palo Alto University3 papers (2012–2017)Bradley G. Hammill · Duke University3 papers (2012–2017)Frederick A. Masoudi · Bristol-Myers Squibb (United States)2 papers (2012–2013)Puza P. Sharma · Novartis (Switzerland)2 papers (2018–2019) · 2 papers (2012–2013)Adam D DeVore · Duke University2 papers (2018–2019)J. Herbert Patterson · South Eastern Health and Social Care Trust2 papers (2018–2019)Carol I. Duffy · Novartis (Switzerland)2 papers (2018–2019)Stephen C. Hammill · Mayo Clinic in Florida2 papers (2012–2013)John A. Spertus · University of Glasgow2 papers (2018–2019)Javed Butler · Jackson College2 papers (2018–2019)Laine Thomas · Duke University2 papers (2018–2019)Melissa A. Greiner · Duke University2 papers (2017–2017) · 2 papers (2018–2019)Eric D. Peterson · Peterson (Norway)2 papers (2012–2018)Nancy M. Albert · Cleveland Clinic2 papers (2018–2019)Robert K. Lewis · Duke Medical Center1 papers (2017–2017)